INVOcell® has the ability to significantly transform the way in which doctors assist infertile patients to become pregnant in a simpler, more natural and cost effective manner. The INVO® Intravaginal Culture (IVC) system provides the Assisted Reproductive Clinics and Physicians around the globe with the ability to offer an additional infertility treatment to hopeful patients. FDA Cleared for use in the US, the INVOcell device and procedure is less expensive than traditional IVF with comparable efficacy and pregnancy rates. The INVO Procedure is simple so it can be easily performed in an appropriately trained physician’s office.
The patented INVOcell is used for the incubation of eggs and sperm during fertilization and early embryo development. Unlike conventional infertility treatments such as in IVF where the eggs and sperm undergo fertilization and early embryo development in a laboratory incubator, the INVOcell utilizes the women’s vagina as a natural incubator to support fertilization and embryo development. INVOcell is not a complex electromechanical device as it relies only on the in vivo environment, the natural vaginal pH, temperature and gasses, as well as the natural body movements.
The INVOcell technology offers patients a more personal approach to achieving pregnancy. It has been proven safe and effective in decreasing the side effects of stimulating drugs when used in association with mild stimulation protocols, reducing the risk of errors in transferring embryos and minimizing the chance for creating unused embryos.
For many couples struggling with infertility, access to treatment is often not available. Financial challenges, limited availability of specialized medical care, religious, social, or cultural roadblocks can prevent these hopeful parents from realizing their dream to have a baby. With the INVO Solution, more and more patients can now receive safe, effective and affordable infertility treatment.
INVOcell has been clinical tested and substantiated on 450 cycles, granting the device FDA clearance. Additionally, over 3,000 cases have been performed across the globe. The success rates for INVOcell are equivalent to traditional IVF. More